Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
NCT00209755
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis C
Interventions
PROCEDURE:
therapeutic drug monitoring of ribavirin and dose adaptation
Sponsor
Hopital A Michallon
Collaborators
[object Object]
[object Object]